{"cik":"0001936258","ticker":"NAMS","name":"NewAmsterdam Pharma Co N.V.","sic_code":"2834","sic_description":"Pharmaceutical Preparations","exchange":"Nasdaq","state_of_incorporation":"P7","fiscal_year_end":"1231","first_filing_date":"2026-05-14","last_filing_date":"2026-07-22","url":"/sec/cik-0001936258","insider_summary":{"total_transactions":13,"unique_insiders":1,"latest_transaction":"2026-07-20"},"recent_filings":[{"accession_number":"0001193125-26-312390","form_type":"8-K","form_type_family":"current","doc_date":"2026-07-22","title":"8-K — NewAmsterdam Pharma Co N.V. — 2026-07-22","url_slug":"/sec/cik-0001936258/8-k/0001193125-26-312390","edgar_url":"https://www.sec.gov/Archives/edgar/data/1936258/0001193125-26-312390-index.html"},{"accession_number":"0001193125-26-312387","form_type":"4","form_type_family":"insider","doc_date":"2026-07-22","title":"4 — NewAmsterdam Pharma Co N.V. — 2026-07-22","url_slug":"/sec/cik-0001936258/4/0001193125-26-312387","edgar_url":"https://www.sec.gov/Archives/edgar/data/1936258/0001193125-26-312387-index.html"},{"accession_number":"0001193125-26-281062","form_type":"4","form_type_family":"insider","doc_date":"2026-06-24","title":"4 — NewAmsterdam Pharma Co N.V. — 2026-06-24","url_slug":"/sec/cik-0001936258/4/0001193125-26-281062","edgar_url":"https://www.sec.gov/Archives/edgar/data/1936258/0001193125-26-281062-index.html"},{"accession_number":"0001193125-26-259794","form_type":"S-8","form_type_family":"other","doc_date":"2026-06-05","title":"S-8 — NewAmsterdam Pharma Co N.V. — 2026-06-05","url_slug":"/sec/cik-0001936258/s-8/0001193125-26-259794","edgar_url":"https://www.sec.gov/Archives/edgar/data/1936258/0001193125-26-259794-index.html"},{"accession_number":"0001422849-26-000108","form_type":"SCHEDULE 13G/A","form_type_family":"other","doc_date":"2026-06-04","title":"SCHEDULE 13G/A — Capital World Investors — 2026-06-04","url_slug":"/sec/cik-0001422849/schedule-13g-a/0001422849-26-000108","edgar_url":"https://www.sec.gov/Archives/edgar/data/1936258/0001422849-26-000108-index.html"},{"accession_number":"0001193125-26-254615","form_type":"8-K","form_type_family":"current","doc_date":"2026-06-03","title":"8-K — NewAmsterdam Pharma Co N.V. — 2026-06-03","url_slug":"/sec/cik-0001936258/8-k/0001193125-26-254615","edgar_url":"https://www.sec.gov/Archives/edgar/data/1936258/0001193125-26-254615-index.html"}],"related_endpoints":{"profile":"/sec/NAMS/profile","timeline":"/sec/NAMS/timeline","peers":"/sec/NAMS/peers","insider_pulse":"/sec/NAMS/insider-pulse","insider_summary":"/sec/NAMS/insider-summary","insider_transactions":"/sec/NAMS/insider-transactions","form144":"/sec/NAMS/form144","holdings_as_filer":"/sec/NAMS/holdings","financial_facts":"/sec/NAMS/financial-facts","derivatives":"/sec/NAMS/derivatives","officers":"/sec/NAMS/officers","insider_network":"/sec/NAMS/insider-network","risk_flags":"/sec/NAMS/risk-flags","filings":"/sec/NAMS/filings","cross_topic_dossier":"/api/v1/dossier?ticker=NAMS"}}